Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy

Gemcitabine plus Capecitabine (Gem/Cape) is a frequently adopted second line chemotherapy for metastatic adrenocortical carcinoma (ACC), but only a minority of patients is destined to obtain a clinical benefit. The identification of baseline predictive factors of efficacy is relevant. We retrospecti...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Endocrinol (Lausanne)
Egile Nagusiak: Grisanti, Salvatore, Cosentini, Deborah, Laganà, Marta, Morandi, Alessandra, Lazzari, Barbara, Ferrari, Laura, Volta, Alberto Dalla, Ambrosini, Roberta, Ferrari, Vittorio Domenico, Sigala, Sandra, Berruti, Alfredo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2021
Gaiak:
Endocrinology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7943871/
https://ncbi.nlm.nih.gov/pubmed/33716976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.624102
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak